Cargando…

High rates of JCV seroconversion in a large international cohort of natalizumab-treated patients

AIMS: To retrospectively assess factors associated with John Cunningham virus (JCV) seroconversion in natalizumab-treated patients. BACKGROUND: Natalizumab is highly effective for the treatment of relapsing–remitting multiple sclerosis (RRMS), but its use is complicated by opportunistic JCV infectio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dwyer, Christopher M., Jokubaitis, Vilija G., Stankovich, Jim, Baker, Josephine, Haartsen, Jodi, Butzkueven, Helmut, Cartwright, Adriana, Shuey, Neil, Fragoso, Yara Dadalti, Rath, Louise, Skibina, Olga, Fryer, Kylie, Butler, Ernest, Coleman, Jennifer, MacIntrye, Jennifer, Macdonell, Richard, van der Walt, Anneke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053827/ https://www.ncbi.nlm.nih.gov/pubmed/33948117 http://dx.doi.org/10.1177/1756286421998915

Ejemplares similares

Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values
por: Schwab, Nicholas, et al.
Publicado: (2016)

JCV seroconversion rate during the SARS COVID-19 pandemic
por: Vigiser, I., et al.
Publicado: (2022)

The MSBase pregnancy, neonatal outcomes, and women’s health registry
por: Jokubaitis, Vilija G., et al.
Publicado: (2021)

Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation
por: Iannetta, Marco, et al.
Publicado: (2016)

Risk of cervical pre-cancer and cancer in women with multiple sclerosis exposed to high efficacy disease modifying therapies
por: Bridge, Francesca, et al.
Publicado: (2023)

Rising JCV-Ab index during natalizumab therapy for MS: Inauspicious for a highly efficacious drug
por: Javed, Adil, et al.
Publicado: (2016)

The unexpected finding of a hemangioblastoma on the cerebellum of a patient undergoing treatment with natalizumab for multiple sclerosis
por: Fragoso, Yara Dadalti, et al.
Publicado: (2017)

Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients
por: Iannetta, Marco, et al.
Publicado: (2019)

Monitoring cognitive change in multiple sclerosis using a computerized cognitive battery
por: De Meijer, L, et al.
Publicado: (2018)

Whole-blood methylation signatures are associated with and accurately classify multiple sclerosis disease severity
por: Campagna, Maria Pia, et al.
Publicado: (2022)

Multiple sclerosis risk variants regulate gene expression in innate and adaptive immune cells
por: Gresle, Melissa M, et al.
Publicado: (2020)

Statistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCV® DxSelect™ antibody assay
por: Campagnolo, Denise, et al.
Publicado: (2016)

Early imaging predictors of longer term multiple sclerosis risk and severity in acute optic neuritis
por: Gajamange, Sanuji, et al.
Publicado: (2019)

JC Virus Encephalopathy Is Associated with a Novel Agnoprotein-Deletion JCV Variant
por: Dang, Xin, et al.
Publicado: (2012)

Increased risk of cervical dysplasia in females with autoimmune conditions—Results from an Australia database linkage study
por: Foster, Emma, et al.
Publicado: (2020)

Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom
por: Spelman, Timothy, et al.
Publicado: (2021)

Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis
por: Campagna, Maria Pia, et al.
Publicado: (2023)

Timely intervention, monitoring and education MATTERS in MS (TIME MATTERS in MS): Development of a globally applicable quality improvement tool
por: Hobart, Jeremy, et al.
Publicado: (2022)

JC Polyomavirus (JCV) and Monoclonal Antibodies: Friends or Potential Foes?
por: Diotti, Roberta Antonia, et al.
Publicado: (2013)

Pur-Alpha Induces JCV Gene Expression and Viral Replication by Suppressing SRSF1 in Glial Cells
por: Sariyer, Ilker Kudret, et al.
Publicado: (2016)

Neural Crest Cells Isolated from the Bone Marrow of Transgenic Mice Express JCV T-Antigen
por: Gordon, Jennifer, et al.
Publicado: (2013)

Bag3-Induced Autophagy Is Associated with Degradation of JCV Oncoprotein, T-Ag
por: Sariyer, Ilker Kudret, et al.
Publicado: (2012)

No detection of EBV, BKV and JCV in breast cancer tissue samples in Iran
por: Dowran, Razieh, et al.
Publicado: (2019)

Anti-JCV antibody index does not change during ocrelizumab-treatment
por: Rempe, Torge, et al.
Publicado: (2020)

Primary bilateral adrenal B-cell lymphoma associated with EBV and JCV infection
por: Barzon, Luisa, et al.
Publicado: (2009)

Changes to anti-JCV antibody levels in a Swedish national MS cohort
por: Warnke, Clemens, et al.
Publicado: (2013)

Encephalitis with coinfection by Jamestown canyon virus (JCV) and varicella zoster virus (VZV)
por: VanderVeen, Nathan, et al.
Publicado: (2020)

Epigenome-wide association studies: current knowledge, strategies and recommendations
por: Campagna, Maria Pia, et al.
Publicado: (2021)

Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results
por: Butzkueven, Helmut, et al.
Publicado: (2014)

Human JCV Infections as a Bio-Anthropological Marker of the Formation of Brazilian Amazonian Populations
por: Cayres-Vallinoto, Izaura M. V., et al.
Publicado: (2012)

Longitudinal analyses of anti-JCV antibody index for risk assessment of progressive multifocal leukoencephalopathy
por: Salmen, A., et al.
Publicado: (2016)

MS, pregnancy and COVID-19
por: Yam, Charmaine, et al.
Publicado: (2020)

Activation of c-Myc and Cyclin D1 by JCV T-Antigen and β-Catenin in Colon Cancer
por: Ripple, Michael J., et al.
Publicado: (2014)

Impact of Disease-Modifying Treatments on the Longitudinal Evolution of Anti-JCV Antibody Index in Multiple Sclerosis
por: Hegen, Harald, et al.
Publicado: (2018)

Comparative efficacy of switching to natalizumab in active multiple sclerosis
por: Spelman, Timothy, et al.
Publicado: (2015)

The Australian Multiple Sclerosis (MS) Immunotherapy Study: A Prospective, Multicentre Study of Drug Utilisation Using the MSBase Platform
por: Jokubaitis, Vilija G., et al.
Publicado: (2013)

JCV viruria associates with suboptimal recovery of kidney function three years after living kidney donation
por: Querido, Sara, et al.
Publicado: (2022)

The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis
por: Merlo, Daniel, et al.
Publicado: (2019)

Natalizumab-induced pneumonitis
por: Kaninia, Stefania, et al.
Publicado: (2021)

Treatment of Women with Multiple Sclerosis Planning Pregnancy
por: Krysko, Kristen M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_64gb6qb286gkb7i5h54pspvtcb